PDS Biotechnology Corp Total Long-Term Debt
PDS Biotechnology Corp (PDSB) had Total Long-Term Debt of $15.00 million as of 2016-09-30, per its 10-Q filed 2016-11-01.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2016-11-01
- 2016-09-30: Long-term Debt $15.00M.
- 2016-06-30: Long-term Debt $4.36M.
- 2016-03-31: Long-term Debt $4.92M.
- 2015-12-31: Long-term Debt $5.47M.
| Period end | Long-term Debt |
|---|---|
| 2016-09-30 | $15.00M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $4.36M 10-Q · filed 2016-08-03 |
| 2016-03-31 | $4.92M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $5.47M 10-K · filed 2016-03-08 |
| 2015-09-30 | $6.00M 10-Q · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |